Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

BACKGROUND: Findings from randomized clinical trials may have limited generalizability to patients treated in routine clinical practice. This study examined the effectiveness of first-line palbociclib plus letrozole versus letrozole alone on survival outcomes in patients with hormone receptor–positi...

詳細記述

保存先:
書誌詳細
出版年:Breast Cancer Res
主要な著者: DeMichele, Angela, Cristofanilli, Massimo, Brufsky, Adam, Liu, Xianchen, Mardekian, Jack, McRoy, Lynn, Layman, Rachel M., Emir, Birol, Torres, Mylin A., Rugo, Hope S., Finn, Richard S.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989035/
https://ncbi.nlm.nih.gov/pubmed/33761995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-021-01409-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料